UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Details
Sales, net	$ 10,479	$ 12,494	$ 30,168	$ 35,073
Cost of goods sold	3,982	5,115	11,885	13,421
Gross profit	6,497	7,379	18,283	21,652
Operating expense
Selling, general and administrative	2,785	2,878	8,480	8,341
Research & development	125	130	375	357
Total operating expenses	2,910	3,008	8,855	8,698
Operating income	3,587	4,371	9,428	12,954
Other income (expense)	1	76	125	196
Income before provision for income taxes	3,588	4,447	9,553	13,150
Provision for income taxes	655	742	2,167	2,781
Net income	$ 2,933	$ 3,705	$ 7,386	$ 10,369
Earnings per common share (basic)	$ 0.81	$ 1.00	$ 2.02	$ 2.79
Earnings per common share (diluted)	$ 0.80	$ 0.99	$ 2.01	$ 2.77
Shares outstanding - basic	3,642	3,720	3,664	3,722
Shares outstanding - diluted	3,653	3,737	3,678	3,738
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ 1,511	$ (1,683)	$ (416)	$ (1,200)
Total comprehensive income	$ 4,444	$ 2,022	$ 6,970	$ 9,169